The present disclosure provides a fluidic device including (a) a first channel including a first inlet and a first outlet, (b) a second channel including a second inlet and a second outlet, wherein the second inlet of the second channel is in fluid communication with the first outlet of the first channel, and (c) a sensor positioned between the first outlet and the second inlet, wherein the sensor includes a sensor configured to deflect in response to a flow between the first channel and the second channel.

Systems, catheters, and methods for accessing and treating along the central nervous system are disclosed. An example method may manage inflammation of the patient to treat a condition of the patient by processing values related to one or more physiological parameters of a patent, identifying when an inflammation condition of the patient has reached a treatment condition based on the processed values, and automatically providing an indication that the inflammation condition has reached the treatment condition. An example indication may include actuation of a treatment protocol. The example method may be performed with an inflammation management system.

Systems, catheters, and methods for accessing and treating along the central nervous system are disclosed. An example method may manage inflammation of the patient to treat a condition of the patient by processing values related to one or more physiological parameters of a patent, identifying when an inflammation condition of the patient has reached a treatment condition based on the processed values, and automatically providing an indication that the inflammation condition has reached the treatment condition. An example indication may include actuation of a treatment protocol. The example method may be performed with an inflammation management system.

Systems, devices, methods, and compositions are described for providing an actively controllable implant configured to, for example, monitor, treat, or prevent microbial growth or adherence to the implant.

An endovascular shunt implantation system includes a guide member configured for being deployed in an inferior petrosal sinus, and a delivery catheter movably coupled to the guide member, wherein a distal end of the delivery catheter includes a tissue penetrating element. A guard is disposed over the tissue penetrating element, the guard having an open distal end portion including an inner surface feature configured to deflect the tissue penetrating element away from the guide member when the tissue penetrating element is translated distally relative to the guard. A shunt delivery shuttle is positioned within, and is movable relative to, the delivery catheter, the shunt delivery shuttle having a distal portion configured to collapse around an elongate shunt body to thereby transport the shunt body through the delivery catheter, wherein the distal portion self-expands to release the shunt body when the distal shuttle portion is advanced out of the delivery catheter.

An intrathecal drug delivery system configured to improve dispersion of medicament with cerebral spinal fluid in a subarachnoid space of a patient. The intrathecal drug delivery system including an implantable medical pump and a catheter having a wall defining a lumen extending between a proximal end in fluid communication with the implantable pump and structure defining a medicament exit positionable within the subarachnoid space of the patient, the wall further defining at least one feature configured to generate vortices within the cerebrospinal fluid for the purpose of improving intrathecal drug dispersion.

The disclosure relates to a cerebrospinal fluid (CSF) shunt for treatment of hydrocephalus, comprising a valve having an inlet port and an outlet port, which ports are for draining CSF, and a control port for regulating the drainage of CSF through the valve according to a hydrostatic pressure provided to the control port, which hydrostatic pressure is dependent on the body position of the patient. The disclosure further relates to a method for treatment of hydrocephalus comprising regulating drainage of CSF based on a hydrostatic pressure that is dependent on the body position of the patient.

Systems, catheters, and methods for accessing and treating along the central nervous system are disclosed. An example method may control operation of a pump of pump/filtration system to facilitate removing cerebrospinal fluid from a patient, filtering the cerebrospinal fluid with a filter module to remove waste product, and returning the filtered cerebrospinal fluid to the patient. Operation of the pump may be adjusted based on a value related to a measure sensed by a sensor in communication with a lumen carrying cerebrospinal fluid through the filtration system.

A hydrocephalus shunt arrangement for draining cerebrospinal fluid (CSF) in a patient includes a ventricle catheter, a first drainage line, a control valve, a second drainage line, and an intracranial device. The ventricle catheter is inserted into a ventricle space of the brain of a patient. The first drainage line is connected to the ventricle catheter. The control valve is connected to the first drainage line and controls the drainage of CSF from the cranium of the patient through the second drainage line into a drainage area inside an abdominal cavity of the patient. The intracranial device is implanted under the skin of the patient in or at the cranium and connected to the ventricle catheter or the control valve. The intracranial device includes a corrugated metal membrane covering a chamber disposed within a rigid housing. The control valve produces a desired, controlled, drainage of excess CSF.

An implantable valve assembly including a drainage catheter having a central lumen transitioning into a plurality of distinct branch lumen made of a shape memory material. A bioabsorbable dip coating secures the distal end of the plural distinct branch lumen together in physical contact with one another. Each branch lumen has an outer perimeter comprising at least one of a first outer surface section and a second outer surface section. In a secured state with the plural distinct branch lumen held together by the dip coating fluid is prohibited from passing through the holes defined in the first outer surface section. Bioabsorbable blocking members disposed about the outer perimeter of the assembled branch lumen mask holes defined in the second outer surface section prohibiting fluid from entering therein. In a time staggered fashion, the bioabsorbable elements absorb exposing new holes through which the fluid drains.